I agree, this is how you do IR when progressing a trial. So many companies don’t say anything and let investors lose confidence for no good reason other than a lack of newsflow. Significant progress though, 70% recruitment and everything on schedule (again, quite common for companies to fall behind schedule when progressing trials). I’m not surprised that so many Pharma players globally are backing this management team with quite hefty upfront and milestone payment to deliver on their promises
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.020(4.08%) |
Mkt cap ! $306.0M | |||
| Open | High | Low | Value | Volume |
| 50.0¢ | 52.0¢ | 49.0¢ | $879.1K | 1.747M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 17916 | 2 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| DXB (ASX) Chart |